News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
ESR Spikes 15%+ after Resumption of Trading, Gets Takeover Proposal Involving Privatization from Starwood Consortium
ESR (01821.HK) resumed trading this morning, and last spiked 15.2% to $11.52, with about 8.355 million shares traded, involving $98.244 million.On 25 April, ESR received a non-bind...
Reset
Send
The window will close in 5 seconds
ESR Spikes 15%+ after Resumption of Trading, Gets Takeover Proposal Involving Privatization from Starwood Consortium
Close
Recommend
2
Positive
6
Negative
6
 
SHORT SELL
 
STOCK INFO

ESR (01821.HK)  0.000 (0.000%)    Short selling $4.85M; Ratio 8.047%   resumed trading this morning, and last spiked 15.2% to $11.52, with about 8.355 million shares traded, involving $98.244 million.

On 25 April, ESR received a non-binding and conditional proposal from a consortium, i.e. Starwood Capital Operations, L.L.C. (for and on behalf of Starwood), Sixth Street Partners, LLC (for and on behalf of certain of its affiliated investment funds and vehicles), and SSW Partners LP (on behalf of itself and its affiliated funds and entities), in relation to a possible privatization of the Company, according to ESR's announcement.

It is contemplated that shareholders will have the ability to choose to receive cash consideration or roll their shares into the go-forward private company. The consortium currently holds 15.7% of the Company's share capital.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-07-26 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.